chemical-categories

Acacia gum

Rivaroxaban

4-(4-Aminophenyl)morpholin-3-one 438056-69-0
(S)-N-Glycidylphthalimide 161596-47-0
(S)-4-(4-(5-(Aminomethyl)-2-oxooxazolidin-3-yl)phenyl)morpholin-3-one hydrochloride 898543-06-1
5-Chlorothiophene-2-carboxylic acid 24065-33-6

Rivaroxaban is a pure (S)-enantiomer. It is an odorless, non-hygroscopic, white to yellowish powder. Rivaroxaban is only slightly soluble in organic solvents (e.g., acetone, polyethylene glycol 400) and is practically insoluble in water and aqueous media.
Rivaroxaban, a FXa inhibitor, is the active ingredient in XARELTO Tablets. XARELTO a kind of orally anticoagulant drug which is used for the prevention of blood clots. Rivaroxaban takes effect through competitively inhibiting free and clot bound factor Xa, which is needed to activate prothrombin (factor II) to thrombin (factor IIa). The later is a serine protease that is required to activate fibrinogen to fibrin, which is the loose meshwork that completes the clotting process.

Hemin Purified

Hemin ex porcine, equine, bovine

Ticagrelor 99%

2-(((3aR,4S,6R,6aS)-6-Amino-2,2-dimethyltetrahydro-3aH-cyclopenta[d][1,3]dioxol-4-yl)oxy)ethanol (2R,3R)-2,3-dihydroxysuccinate 376608-65-0
(3aR,4S,6R,6aS)-6-Amino-2,2-dimethyltetrahydro-3aH-cyclopenta[d][1,3]dioxol-4-ol 155899-66-4
2-(((3aR,4S,6R,6aS)-6-Amino-2,2-dimethyltetrahydro-3aH-cyclopenta[d][1,3]dioxol-4-yl)oxy)ethanol 274693-55-9
(1R,2S)-2-(3,4-Difluorophenyl)cyclopropanamine (R)-2-hydroxy-2-phenylacetate 376608-71-8
(1R,2S)-2-(3,4-Difluorophenyl)cyclopropanamine 220352-38-5
(1R,2S)-rel-2-(3,4-Difluorophenyl)cyclopropanamine hydrochloride 1156491-10-9
4,6-Dichloro-2-(propylthio)pyrimidin-5-amine 145783-15-9
4,6-Dichloro-5-nitro-2-(propylthio)pyrimidine 145783-14-8

Ticagrelor, a new platelet aggregation inhibitor successfully developed by AstraZeneca (U.S.), is the world’s first reversible combination orally-administered P2Y12 adenosine diphosphate receptor antagonist.
It is used to reduce cardiovascular death and heart attacks in patients with acute coronary syndrome (ACS.) Rapid onset after oral administration, and can effectively improve symptoms of patients with ACS. Thienopyridin

Tranexamic Acid

Tranexamic acid is a synthetic derivative of the amino acid lysine. It is used to treat or prevent excessive blood loss during surgery and in various other medical conditions. It is an antifibrinolytic that competitively inhibits the activation of plasminogen to plasmin, by binding to specific sites of both plasminogen and plasmin, a molecule responsible for the degradation of fibrin. Tranexamic acid is frequently used in surgeries with high risk of blood loss such as cardiac, liver, vascular and large orthopedic procedures. Its oral form is now being evaluated for use in outpatient conditions involving heavy bleeding. Tranexamic acid competitively inhibits activation of plasminogen (via binding to the kringle domain), thereby reducing conversion of plasminogen to plasmin. Tranexamic acid also directly inhibits plasmin activity, but higher doses are required than are needed to reduce plasmin formation.

Camostat Mesilate

Camostat Mesilate is derivative of gabexate mesilate.It is a drug suitable for oral administration and widely used for treatment of chronic pancreatitis.It inhibits prostasin activity and reduces blood pressure and renal injury in salt-sensitive hypertension.

Thrombin Purified

Thrombin ex Bovine

Doxazosin Mesylate

Doxazosin Mesylate is a medication used in the treatment of high bloodstream pressure and signs and symptoms of harmless prostatic hyperplasia. It stops norepinephrine that's revealed by nerve fibres from joining to alpha-1 receptors on simple muscle tissue adjoining veins and in the prostate as well as bladder. By preventing the result of norepinephrine, Doxazosin relaxes the particular smooth muscle tissue. Relaxation in the smooth muscle tissue surrounding veins leads to them to expand (dilate) as well as thereby decreases bloodstream pressure. Relaxation of smooth muscle tissue in the prostate as well as bladder increases the circulation of urine along with decreases the discomfort and pain characteristic of BPH.

Ferric citrate USP

Candesartan Cilexetil

Candesartan Cilexetil is a prodrug, is hydrolyzed to candesartan during absorption from the gastrointestinal tract. Candesartan Cilexetil is rapidly and completely bioactivated by ester hydrolysis during absorption from the gastrointestinal tract to candesartan, a selective AT1 subtype angiotensin II receptor antagonist. Candesartan Cilexetil is a drug used for treating high blood pressure (hypertension). It is in a class of drugs called angiotensin receptor blockers (ARBs) and indicated for the treatment of patients with hypertension and patients with chronic heart failure(CHF) and left ventricular systolic dysfunction.